Carbamimidothioic acid,2-(dimethylamino)ethyl ester, hydrochloride (1:2) cas no:16111-27-6

NameCarbamimidothioic acid,2-(dimethylamino)ethyl ester, hydrochloride (1:2)
CAS16111-27-6
SynonymsCarbamimidothioicacid, 2-(dimethylamino)ethyl ester, dihydrochloride (9CI); Pseudourea,2-[2-(dimethylamino)ethyl]-2-thio-, dihydrochloride (8CI); Nordimaprit; SKF91487
EINECS(EC#)240-281-9
Molecular FormulaC5H13 N3 S . 2 Cl H
Molecular Weight220.19

refractive index1.54

Safety

Poison by subcutaneous, intravenous, and intraperitoneal routes. When  Nordimaprit (CAS NO.16111-27-6) is heated to decomposition, it emits toxic fumes of NO_x, SO_x, and HCl.

Risk Statements 36/37/38
R36/37/38: Nordimaprit (CAS NO.16111-27-6) is irritating to eyes, respiratory system and skin.
Safety Statements 26-36/37/39
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
RTECS UM3770000

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	150mg/kg (150mg/kg)		Yakugaku Zasshi. Journal of Pharmacy. Vol. 92, Pg. 442, 1972.
mouse	LD50	intravenous	49100ug/kg (49.1mg/kg)		Yakugaku Zasshi. Journal of Pharmacy. Vol. 88, Pg. 156, 1968.
mouse	LD50	subcutaneous	63mg/kg (63mg/kg)		Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 576, 1957.